BioSpace News Archive

Business

Powerful U.S. Political and Business Leaders Lost Hundreds of Millions on Theranos

Failed blood-testing developer Theranos was known for its high-profile supporters who had tremendous business and political clout. Names like Rupert Murdoch, Betsy Devos and James Baker were known investors in the company.

May 7, 2018

·

2 min read

·

Alex Keown

Drug Development

Australia’s Biotech Sector Expected to Show Modest Growth by 2025

The Australian biotech market, which was valued at nearly $23 billion last year, is expected to see some positive growth to $25.2 billion by 2025, according to a GlobalData analysis.

May 7, 2018

·

3 min read

·

Alex Keown

Drug Development

FDA Gives Genentech’s Tecentriq Priority Review for Triple-Combo Lung Cancer Treatment

The U.S. Food and Drug Administration (FDA) granted Genentech’s Tecentriq triple combination with Avastain (bevacizumab), paclitaxel and carboplatin (chemotherapy) Priority Review for first-line treatment of patients with metastatic non-squamous non-small cell lung cancer (NSCLC).

May 7, 2018

·

2 min read

·

Mark Terry

Job Trends

New Report Outlines Steps to Keep U.S. Life Sciences Competitive Globally

The Information Technology & Innovation Foundation recently published a report diving into the U.S.’s trade deficits in the life sciences industry worldwide and steps that can be made to keep the biopharma and medical device industries competitive globally.

May 7, 2018

·

2 min read

·

Mark Terry

Policy

Predicting the Unpredictable: This Week Trump Expected to Address Drug Pricing

Barring yet another headline-leading scandal, confrontational tweet or TV talk-show rant, Trump is expected to offer a speech on his administration’s policies toward drug pricing this week.

May 7, 2018

·

4 min read

·

Mark Terry

Drug Development

Three Profiles: When Big Pharma Execs Opt to Lead Biotech Startups

Pharmaceutical execs who leave their positions with big pharmaceutical companies, unless opting to retire for good, often move to leadership positions at other big companies. There are other choices.

May 7, 2018

·

5 min read

·

Mark Terry

Close up picture of young man holding senior disabled woman's hand - blue bathrobe background

Drug Development

Charles River Laboratories and Michael J. Fox Foundation Extend Collaboration

The Wilmington, Massachusetts-based contract research organization (CRO) Charles River Laboratories International extended its current collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

May 7, 2018

·

3 min read

·

Mark Terry

Drug Development

Gene Therapies for Hemophilia Could Hit $1.5 Million, Analysts Speculate

As we get closer to seeing the U.S. Food and Drug Administration green light the first gene therapy for hemophilia, analysts estimate that the cost of the probable one-time treatment could have a whopping price-tag of $1.5 million.

May 7, 2018

·

2 min read

·

Alex Keown

Drug Development

Janssen Closes in on Seeking FDA Approval for Ketamine-Based Depression Treatment

Janssen Pharmaceuticals is eying a potential breakthrough in treating refractory major depressive disorder.

May 7, 2018

·

2 min read

·

Alex Keown

Business

Biotech Companies Continue to Shake Up Leadership with New Appointments

There have been a number of leadership changes in biotech companies over the last week. BioSpace has put together a list of new c-suite level hires and position changes.

May 7, 2018

·

3 min read

·

Alex Keown